OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury
Yingying Qian, Cheng Qian, Kewei Xie, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
Wenhui Tao, Xi-sheng Shan, Jiaxin Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 74

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 62

ATP ion channel P2X purinergic receptors in inflammation response
Jipeng Liu, Si-cheng Liu, Shiqi Hu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114205-114205
Open Access | Times Cited: 31

Repurposing the familiar: Future treatment options against chronic kidney disease
Rohan Bhadange, Anil Bhanudas Gaikwad
Journal of Pharmacy and Pharmacology (2025)
Closed Access | Times Cited: 1

Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism
Ruo-Ying Li, Liang Guo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3605-3605
Open Access | Times Cited: 6

Novel insights into NOD-like receptors in renal diseases
Juan Jin, Tao-jie Zhou, Gui‐Ling Ren, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 11, pp. 2789-2806
Open Access | Times Cited: 25

Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury
Elena Roger, Christos Chadjichristos, Panagiotis Kavvadas, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12

Wuling San regulates AVPR2-cAMP-PKA-CREB pathway to delay cellular senescence and ameliorate acute kidney injury.
Hong Liu, Manxue Mei, Shuyin Lin, et al.
Journal of Ethnopharmacology (2025), pp. 119679-119679
Closed Access

Animal Models for the Investigation of P2X7 Receptors
Ronald Sluyter, Sahil Adriouch, Stephen J. Fuller, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8225-8225
Open Access | Times Cited: 10

Design, Synthesis, and Biological Evaluation of Novel P2X7 Receptor Antagonists for the Treatment of Septic Acute Kidney Injury
Ruijia Zhang, Kaiyue Su, Letian Yang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11365-11389
Closed Access | Times Cited: 9

Inhibition of P2X7R alleviates neuroinflammation and brain edema after traumatic brain injury by suppressing the NF-κB/NLRP3 inflammasome pathway
Bingyan Tao, Jie Pei, Hao Li, et al.
Journal of Neurorestoratology (2024) Vol. 12, Iss. 2, pp. 100106-100106
Open Access | Times Cited: 3

Two Single Nucleotide Polymorphisms in the Purinergic Receptor P2X7 Gene Are Associated with Disease Severity in Multiple Sclerosis
Franca Rosa Guerini, Cristina Agliardi, Elisabetta Bolognesi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15381-15381
Open Access | Times Cited: 12

P2X7R/AKT/mTOR signaling mediates high glucose-induced decrease in podocyte autophagy
Qian Cheng, Jiayue Lu, Xiajing Che, et al.
Free Radical Biology and Medicine (2023) Vol. 204, pp. 337-346
Closed Access | Times Cited: 6

Co-treatment with Esculin and erythropoietin protects against renal ischemia–reperfusion injury via P2X7 receptor inhibition and PI3K/Akt activation
Walaa H. El-Maadawy, Marwa Hassan, Ehab Hafiz, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9

Probenecid induces the recovery of renal ischemia/reperfusion injury via the blockade of Pannexin 1/P2X7 receptor axis
Walaa H. El-Maadawy, Marwa Hassan, Mohamed Badawy, et al.
Life Sciences (2022) Vol. 308, pp. 120933-120933
Closed Access | Times Cited: 8

Secreted phosphoprotein 1 exacerbates renal ischemia-reperfusion injury by inhibiting PI3K/AKT signaling pathway
Bokang Zhang, Wan Yang, Lanren Chen
Tissue and Cell (2023) Vol. 83, pp. 102154-102154
Closed Access | Times Cited: 4

Molecular insights into P2X signalling cascades in acute kidney injury
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 477-486
Open Access | Times Cited: 1

Syringic acid loaded silver nanoparticles protects ovarian ischemia-reperfusion injury in rats by inhibiting endoplasmic reticulum stress-mediated apoptosis
Elif Erbaş, Seçkin Özkanlar, Ali Yeşildağ, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105944-105944
Closed Access | Times Cited: 1

Upregulation of P2X7 Exacerbates Myocardial Ischemia–Reperfusion Injury through Enhancing Inflammation and Apoptosis in Diabetic Mice
Fancan Wu, Hong Wei, Yingxin Hu, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 12, pp. 1962-1973
Open Access | Times Cited: 3

Immune Response Studies Based on P2X7 Receptors: A Mini-Review
Ying Deng, Mengting Zhou, Xingtao Zhao, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 12, pp. 993-999
Closed Access | Times Cited: 5

Therapeutic Potential of P2X7 Purinergic Receptor Modulation in the Main Organs Affected by the COVID-19 Cytokine Storm
Júlia Leão Batista Simões, Leilane Dayane Sobierai, Stefany Maciel Pereira, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 22, pp. 1798-1814
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top